Author: Higashijima Yoshiki Tanaka Tetsuhiro Nangaku Masaomi
Publisher: Informa Healthcare
ISSN: 1746-0441
Source: Expert Opinion on Drug Discovery, Vol.8, Iss.8, 2013-11, pp. : 965-976
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Yan Lin Colandrea Vincent J Hale Jeffrey J
Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. :
Hypoxia-Inducible Factor: A Potential Therapeutic Target for Rheumatoid Arthritis
Current Drug Targets, Vol. 14, Iss. 6, 2013-06 ,pp. :
By Li Ching-Hao Liao Po-Lin Yang Ya-Ting Huang Shih-Hsuan Lin Cheng-Hui Cheng Yu-Wen Kang Jaw-Jou
Archives of Toxicology, Vol. 88, Iss. 3, 2014-03 ,pp. :
HIF prolyl hydroxylase inhibitors for anemia
By Muchnik Eugene Kaplan Joshua
Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. :
By Tamáási Lilla Müüller Veronika Eszes Noéémi Kardos Tamáás Budai Marianna Vincze Krisztina Losonczy Gyöörgy Szilasi Máária
Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. :